HeartSciences Inc. (HSCS)
About HeartSciences Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $4.3K
- Net income
- -$8.8M
- Total assets
- $4.2M
- Market cap
- $6.2M
- Gross margin
- 56.8%
- Operating margin
- -192013.1%
- Net margin
- -201499.5%
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $4.3K
- Cost of revenue
- $1.9K
- Gross profit
- $2.5K
- Operating expenses
- $8.4M
- Operating income
- -$8.4M
- Net income
- -$8.8M
- EPS (basic)
- $-9.34
- EPS (diluted)
- $-9.34
Balance sheet
- Total assets
- $4.2M
- Current assets
- $2.2M
- Total liabilities
- $4.0M
- Current liabilities
- $3.7M
- Shareholders’ equity
- $205.2K
Cash flow
- Operating cash flow
- -$7.4M
- Investing cash flow
- -$30.2K
- Financing cash flow
- $2.7M
- Net cash flow
- -$4.7M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $6.2M
- EPS (diluted)
- $-9.34
- Shares outstanding
- 2.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 15, 2022
HeartSciences Inc. (HSCS) Stock Price
- Reported a net loss of $8.8M in FY2025.
- Revenue declined 16% from FY2023 to FY2025.
- Gross margin of 56.8%, net margin -201499.5%.
- Trading 58% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review HeartSciences Inc..
Write a review
News about HeartSciences Inc.
News & sentiment via Polygon.io
HeartSciences Inc.: frequently asked questions
Is HeartSciences Inc. an American company?
HeartSciences Inc. is a US-based company headquartered in Southlake, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is HeartSciences Inc. headquartered?
HeartSciences Inc. is headquartered in Southlake, Texas, United States.
Is HeartSciences Inc. publicly traded?
Yes — HeartSciences Inc. is a publicly traded company. Its stock trades under the ticker symbol HSCS on the NASDAQ.
What does HeartSciences Inc. do?
HeartSciences Inc. is an American Medical Devices company in the Health & Beauty sector.
